Early use of steroids in children hospitalized for COVID-19 without MIS-C not associated with shorter length of stay
Risk for Type 1 Diabetes in Children May Rise After COVID-19
Increased risk persists for up to six months postinfection for pediatric patients aged 0 to 18 years
Change Seen in Pediatric Respiratory Infection Trends After SARS-CoV-2 Emergence
During April 2020 to May 2021, many respiratory viruses circulated at lower-than-expected levels
Persistent Pulmonary Dysfunction Seen in Children After COVID-19
Persistent pulmonary dysfunction seen for those who have recovered from COVID-19 and with long COVID
Pediatric Brain Abscess, Empyema Hospitalizations Peaked in March 2022
March 2022 peak in cases linked to Streptococcus species consistent with historical seasonal fluctuations seen since 2016
Parental Intent to Vaccinate Under 5s Against COVID-19 Examined
Odds of intending to vaccinate their children was lower for parents three months after a baseline survey versus baseline
Cases of Youth-Onset Type 2 Diabetes Climbed During Pandemic
Substantial increase in new cases seen during first year of pandemic
SARS-CoV-2 Infections Frequently Asymptomatic in Children
Infections most often asymptomatic for children aged 0 to 4 years; for adults, but not children, number of symptoms linked to viral load
School-Aged Children Can Self-Swab for COVID-19 Testing
Close agreement seen between self-collected nasal swabs and swabs collected by health care workers for SARS-CoV-2 testing results
Pfizer COVID-19 Vaccines 73 Percent Protective in Under 5s
Specially formulated doses for America’s youngest children were approved for distribution in June